Yi‐Hui Peng

Structure-Based Drug Design and Structural Biology Study of Novel Nonpeptide Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Main Protease

I-Lin Lu, Neeraj Mahindroo, Po‐Huang Liang et al. · Journal of Medicinal Chemistry · 2006 · 172 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Important Hydrogen Bond Networks in Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitor Design Revealed by Crystal Structures of Imidazoleisoindole Derivatives with IDO1

Yi‐Hui Peng, Shau‐Hua Ueng, Chen‐Tso Tseng et al. · Journal of Medicinal Chemistry · 2015 · 136 citations · Full text

Pharmacy, Chemical Biology, Medicinal Chemistry +16

Structure-Based Drug Design of a Novel Family of PPARγ Partial Agonists:  Virtual Screening, X-ray Crystallography, and in Vitro/in Vivo Biological Activities

I-Lin Lu, Chien-Fu Huang, Yi‐Hui Peng et al. · Journal of Medicinal Chemistry · 2006 · 98 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Fast-Forwarding Hit to Lead: Aurora and Epidermal Growth Factor Receptor Kinase Inhibitor Lead Identification

Mohane Selvaraj Coumar, Chang‐Ying Chu, Cheng‐Wei Lin et al. · Journal of Medicinal Chemistry · 2010 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Identification of Substituted Naphthotriazolediones as Novel Tryptophan 2,3-Dioxygenase (TDO) Inhibitors through Structure-Based Virtual Screening

Jian‐Sung Wu, Shu‐Yu Lin, Fang-Yu Liao et al. · Journal of Medicinal Chemistry · 2015 · 60 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17